blueprintlogo
  • HOME
  • CAREERS
  • CONTACT US
  • PRIVACY POLICY
  • About
  • Team
  • Services
  • Clients

Execution Driven Corporate Advisory & Investor Relations


Newsroom


  • Could Kenvue Follow in the Footsteps of Johnson & Johnson and Become a Top Dividend Stock?

    Sunday October 01, 2023
  • CRISPR Therapeutics AG (CRSP) Dips More Than Broader Markets: What You Should Know

    Friday September 29, 2023
  • A Look At The Intrinsic Value Of Medtronic plc (NYSE:MDT)

    Saturday September 30, 2023
  • 3 Stocks to Buy in October That Could Soar More Than 40% Over the Next 12 Months, According to Wall Street

    Sunday October 01, 2023


Blueprint Life Science Group © 2023 - All Rights Reserved